Lonardo A, Sookoian S, Chonchol M, et al. Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease -Atherosclerosis As a Major Player in the Natural Course of NAFLD[J].Curr Pharm Des,2013,19(29):5177-5192.
[2]
Musso G, Anty R, Petta S. Antioxidant Therapy and Drugs Interfering with Lipid Metabolism: Could They Be Effective in NAFLD Patients[J].Curr Pharm Des,2013,19(29):5297-313.
[3]
Ahmed M H, Barakat S, Almobarak A O. Nonalcoholic fatty liver disease and cardiovascular disease: has thetime come for cardiologists to be hepatologists[J].J Obes,2012,2012(48):31-35.
[4]
Greenfield V, Cheung O, Sanyal A J. Recent advances in nonalcholic fatty liver disease[M]. Curr Opin Gastroenterol,2008,24(3):320-327.
[5]
Kashi M R, Torres D M, Harrison S A. Current and emerging therapies in nonalcoholic fatty liver disease[J]. Semin Liver Dis,2008,28(4):396-406.
[6]
Polyzos S A, Kountouras J, Zavos C. Nonalcoholic atty liver disease: the pathogenetic roles of insulin esistance and adipocytokines[J].Curr Mol Med,2009,9(3):299-314.
[7]
Schwenzer N F,Springer F, Schraml C, et al. Noninvasive ssessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance [J]. Hepatol, 2009, 51(3):433-445.
[8]
Ophir J,CesPedes I,Ponnekanti H,et al.Elastography:a quantitative method for imaging the elasticity of biologieal tissues[J].Uhrason Imaging,1991,13(2):111-134.
Astera L,Pinzani M.Biopsy and non·invasivc methods for the diagnosis of liver fibrosis:does it take two to tango[J].Gut,2010, 59(7):861-865.
[13]
Deffieux T, Montaldo G, Tanter M, et al. Shear wave spectroscopy for in vivo quantification of human soft tissues visco-elasticity [J].IEEE Trans Med Imaging, 2009, 28(3):313-322.
[14]
Orlacchio A, Bolacchi F, Antonicoli M, et al. Liver elasticity in NASH patients evaluated with real-time elastography (RTE) [J]. Ultrasound Med Biol, 2012, 38(4):537-538.
Yoneda M, Mawatari H, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD) [J].Dig Liver Dis, 2008, 40(5):371-378.
[17]
Oh MK, Winn J, Poordad F. Review article: diagnosis and treatment of non-alcoholicfatty liver disease [J].Aliment Pharmacol Ther, 2008, 28(5):503-522.
[18]
Degos F, Perez P, Roche B, et al. Diagnostic accuracy of Fibroscan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study) [J]. J Hepatol, 2010, 53(6): 1013-1021.
[19]
Myers R P, Pollett A, Kirsch R, et al. Controlled attenuation parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography [J]. Liver Int, 2012, 32(6):902-910.
Friedrich, Rust M,Wunder K,et al.Liver fibrosis in viral hepatitis:noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography [J].Radiology,2009,252(2):595-604.
Ying L, Lin X, Xie Z L, et al. Clinical utility of acoustic radiation force impulse imaging for identification of malignant liver lesions: a meta-analysis [J]. Eur Radiol,2012,22(12):2798-2805.
[26]
Yu H, Wilson S R. Differentiation of benign from malignant liver masses with Acoustic Radiation Force Impulse technique [J]. Ultrasound Q, 2011, 27(4):217-223.
[27]
Fahey B J, Nelson R C, Hsu S J, et al. In vivo guidance and assessment of liver radio frequency ablation with acoustic radiation force[J].Ultrasound Med Biol, 2008,34 (10):1590-1603.
Guzmfin Aroca F,Ayala I,Serrano L,et al. Assessment of liver steatosis in chicken by using acoustic radiation force impulse imaging: preliminary results[J]. Eur Radiol,2010,20(10):2367-2371.
Yoneda M, Suzuki K, Kato S, et al. Nonalcoholic fatty liver disease: US based acoustic radiation force impulse elastography[J].Radiology,2010,256(2):640-647.
[32]
Palmeri M L, Wang M H, Rouze N C, et al. Noninvasive evaluation of hepatic fibrosis using acoustic radiation force based shear stiffness in patients with nonalcoholic fatty liver disease [J]. J Hepatol, 2011, 55(3): 666-672.
[33]
Lupsor M, Badea R, Stefanescu H, et al. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients[J]. J Gastrointestin Liver Dis, 2008, 17(2):155-163.
2016, Vol. 27 
